This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 200501-088OCv1 173/7/718    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Henderson, W. R. Articles by Chi, E. Y. Search for Related Content PubMed PubMed Citation Articles by Henderson, W. R., Jr. Articles by Chi, E. Y.

Reversal of Allergen-induced Airway Remodeling by CysLT₁ Receptor Blockade

Center for Allergy and Inflammation, Departments of Medicine and Pathology, University of Washington, Seattle, Washington

Correspondence and requests for reprints should be addressed to William R. Henderson, Jr., M.D., Center for Allergy and Inflammation, Department of Medicine, Allergy and Inflammation Center, Box 358050, University of Washington, 815 Mercer Street, Seattle, WA 98109-8050. E-mail: joangb{at}u.washington.edu

Rationale: Airway inflammation in asthma is accompanied by structural changes, including goblet cell metaplasia, smooth muscle cell layer thickening, and subepithelial fibrosis. This allergen-induced airway remodeling can be replicated in a mouse asthma model.

Objectives: The study goal was to determine whether established airway remodeling in a mouse asthma model is reversible by administration of the cysteinyl leukotriene (CysLT)₁ receptor antagonist montelukast, the corticosteroid dexamethasone, or the combination montelukast + dexamethasone.

Methods: BALB/c mice, sensitized by intraperitoneal ovalbumin (OVA) as allergen, received intranasal OVA periodically Days 14–73 and montelukast or dexamethasone or placebo from Days 73–163.

Measurements and Main Results: Allergen-induced trafficking of eosinophils into the bronchoalveolar lavage fluid and lung interstitium and airway goblet cell metaplasia, smooth muscle cell layer thickening, and subepithelial fibrosis present on Day 73 persisted at Day 163, 3 mo after the last allergen challenge. Airway hyperreactivity to methacholine observed on Day 73 in OVA-treated mice was absent on Day 163. In OVA-treated mice, airway eosinophil infiltration and goblet cell metaplasia were reduced by either montelukast or dexamethasone alone. Montelukast, but not dexamethasone, reversed the established increase in airway smooth muscle mass and subepithelial collagen deposition. By immunocytochemistry, CysLT₁ receptor expression was significantly increased in airway smooth muscle cells in allergen-treated mice compared with saline-treated controls and was reduced by montelukast, but not dexamethasone, administration.

Conclusions: These data indicate that established airway smooth muscle cell layer thickening and subepithelial fibrosis, key allergen-induced airway structural changes not modulated by corticosteroids, are reversible by CysLT₁ receptor blockade therapy.

Key Words: eosinophils • fibrosis • mucus • smooth muscle

This article has been cited by other articles:

				S. K. Huang and M. Peters-Golden Eicosanoid Lipid Mediators in Fibrotic Lung Diseases: Ready for Prime Time? Chest, June 1, 2008; 133(6): 1442 - 1450. [Abstract] [Full Text] [PDF]

				N. Regamey, M. Ochs, T. N. Hilliard, C. Muhlfeld, N. Cornish, L. Fleming, S. Saglani, E. W. F. W. Alton, A. Bush, P. K. Jeffery, et al. Increased Airway Smooth Muscle Mass in Children with Asthma, Cystic Fibrosis, and Non-Cystic Fibrosis Bronchiectasis Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 837 - 843. [Abstract] [Full Text] [PDF]

				B. D. Levy, N. W. Lukacs, A. A. Berlin, B. Schmidt, W. J. Guilford, C. N. Serhan, and J. F. Parkinson Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism FASEB J, December 1, 2007; 21(14): 3877 - 3884. [Abstract] [Full Text] [PDF]

				M. Peters-Golden and W. R. Henderson Jr. Leukotrienes N. Engl. J. Med., November 1, 2007; 357(18): 1841 - 1854. [Full Text] [PDF]

				R. P. Vieira, R. C. Claudino, A. C. S. Duarte, A. B. G. Santos, A. Perini, H. C. C. Faria Neto, T. Mauad, M. A. Martins, M. Dolhnikoff, and C. R. F. Carvalho Aerobic Exercise Decreases Chronic Allergic Lung Inflammation and Airway Remodeling in Mice Am. J. Respir. Crit. Care Med., November 1, 2007; 176(9): 871 - 877. [Abstract] [Full Text] [PDF]

				R. Gosens, G. Dueck, E. Rector, R. O. Nunes, W. T. Gerthoffer, H. Unruh, J. Zaagsma, H. Meurs, and A. J. Halayko Cooperative regulation of GSK-3 by muscarinic and PDGF receptors is associated with airway myocyte proliferation Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1348 - L1358. [Abstract] [Full Text] [PDF]

				W. R. Henderson Jr., E. Y. Chi, J. G. Bollinger, Y.-t. Tien, X. Ye, L. Castelli, Y. P. Rubtsov, A. G. Singer, G. K.S. Chiang, T. Nevalainen, et al. Importance of group X-secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model J. Exp. Med., April 16, 2007; 204(4): 865 - 877. [Abstract] [Full Text] [PDF]

				W. C. Moore and S. P. Peters Update in Asthma 2006 Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 649 - 654. [Full Text] [PDF]

				E. D. Fixman, A. Stewart, and J. G. Martin Basic mechanisms of development of airway structural changes in asthma Eur. Respir. J., February 1, 2007; 29(2): 379 - 389. [Abstract] [Full Text] [PDF]

				M. M. Kelly, J. Chakir, D. Vethanayagam, L.-P. Boulet, M. Laviolette, J. Gauldie, and P. M. O'Byrne Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge. Chest, September 1, 2006; 130(3): 741 - 753. [Abstract] [Full Text] [PDF]